Abstract:Background: Prostate cancer remains the second deadliest cancer for American men despite clinical advancements. Currently, magnetic resonance imaging (MRI) is considered the most sensitive non-invasive imaging modality that enables visualization, detection, and localization of prostate cancer, and is increasingly used to guide targeted biopsies for prostate cancer diagnosis. However, its utility remains limited due to high rates of false positives and false negatives as well as low inter-reader agreements. Purpose: Machine learning methods to detect and localize cancer on prostate MRI can help standardize radiologist interpretations. However, existing machine learning methods vary not only in model architecture, but also in the ground truth labeling strategies used for model training. We compare different labeling strategies and the effects they have on the performance of different machine learning models for prostate cancer detection on MRI. Methods: Four different deep learning models (SPCNet, U-Net, branched U-Net, and DeepLabv3+) were trained to detect prostate cancer on MRI using 75 patients with radical prostatectomy, and evaluated using 40 patients with radical prostatectomy and 275 patients with targeted biopsy. Each deep learning model was trained with four different label types: pathology-confirmed radiologist labels, pathologist labels on whole-mount histopathology images, and lesion-level and pixel-level digital pathologist labels (previously validated deep learning algorithm on histopathology images to predict pixel-level Gleason patterns) on whole-mount histopathology images. The pathologist and digital pathologist labels (collectively referred to as pathology labels) were mapped onto pre-operative MRI using an automated MRI-histopathology registration platform. Results: Radiologist labels missed cancers (ROC-AUC: 0.75-0.84), had lower lesion volumes (~68% of pathology lesions), and lower Dice overlaps (0.24-0.28) when compared with pathology labels. Consequently, machine learning models trained with radiologist labels also showed inferior performance compared to models trained with pathology labels. Digital pathologist labels showed high concordance with pathologist labels of cancer (lesion ROC-AUC: 0.97-1, lesion Dice: 0.75-0.93). Machine learning models trained with digital pathologist labels had the highest lesion detection rates in the radical prostatectomy cohort (aggressive lesion ROC-AUC: 0.91-0.94), and had generalizable and comparable performance to pathologist label-trained-models in the targeted biopsy cohort (aggressive lesion ROC-AUC: 0.87-0.88), irrespective of the deep learning architecture. Moreover, machine learning models trained with pixel-level digital pathologist labels were able to selectively identify aggressive and indolent cancer components in mixed lesions on MRI, which is not possible with any human-annotated label type. Conclusions: Machine learning models for prostate MRI interpretation that are trained with digital pathologist labels showed higher or comparable performance with pathologist label-trained models in both radical prostatectomy and targeted biopsy cohort. Digital pathologist labels can reduce challenges associated with human annotations, including labor, time, inter- and intra-reader variability, and can help bridge the gap between prostate radiology and pathology by enabling the training of reliable machine learning models to detect and localize prostate cancer on MRI.

On the Feasibility of Machine Learning Augmented Magnetic Resonance for Point-of-Care Identification of Disease

An Automated Hybrid Approach Via Deep Learning and Radiomics Focused on the Midbrain and Substantia Nigra to Detect Early-Stage Parkinson’s Disease

The MRI Scanner as a Diagnostic: Image-less Active Sampling

Adaptive Sampling of k-Space in Magnetic Resonance for Rapid Pathology Prediction

Multi-Disease Diagnosis Using Medical Images

Bridging the gap between prostate radiology and pathology through machine learning

Automated Triage of Screening Breast MRI Examinations in High-Risk Women Using an Ensemble Deep Learning Model

An Algorithm to Predict the Need for Magnetic Resonance Imaging to Support Disease Monitoring in Multiple Sclerosis

Detecting Underdiagnosed Medical Conditions with Deep Learning-Based Opportunistic CT Imaging

Segmentation and Detection of Brain Tumor by using Machine Learning

Generating Magnetic Resonance Spectroscopy Imaging Data of Brain Tumours from Linear, Non-linear and Deep Learning Models

MRI‐Based Breast Cancer Classification and Localization by Multiparametric Feature Extraction and Combination Using Deep Learning

A Collaborative Approach for the Development and Application of Machine Learning Solutions for CMR-Based Cardiac Disease Classification

Diagnosis of Prostate Cancer Using GLCM Enabled KNN Technique by Analyzing MRI Images

Machine learning applications in prostate cancer magnetic resonance imaging

Real-Time Magnetic Tracking and Diagnosis of COVID-19 via Machine Learning

Enhanced approach for brain tumor detection

Abstract A088: Utilizing Machine Learning Techniques to Investigate Mammograms for Breast Cancer Detection

Evaluation of Machine Learning Classification Models for False-Positive Reduction in Prostate Cancer Detection Using MRI Data

Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities

Exploiting K-Space in Magnetic Resonance Imaging Diagnosis: Dual-Path Attention Fusion for K-Space Global and Image Local Features